Gregor Strobbe (Koios Care)
Overview
Gregor Strobbe is a notable entrepreneur in the field of digital health technology, currently residing in Belgium. Strobbe is a key figure in the HealthTech startup Koios Care, which he co-founded with other partners including Konstantinos Kyritsis and Dimitris Iakovakis. Koios Care is dedicated to improving the monitoring and management of neurological conditions, starting with Parkinson’s disease. The company leverages AI-powered digital platforms to collect and analyze data from everyday devices such as smartphones and smartwatches, providing real-world insights that improve patient care and accelerate medical research.
Recent Developments
- June 2025: Koios Care, under the leadership of Gregor Strobbe and associates, secured a €1 million funding round led by Evercurious VC with participation from Astylab Ventures and others. This funding is intended to expand their digital health tool "Parkiwatch" across European clinics and enhance regulatory clearance efforts. source
- 2023: Koios Care implemented its Parkiwatch platform across various European clinics, marking significant progress in the practical application of their technology. source
- January 2023: The startup successfully completed a €350,000 funding round led by the Flemish venture capital fund Lumiares to support the development and improvement of its technology using advanced AI algorithms. source
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Gregor Strobbe |
| Nationality | Belgian |
| Occupation | Entrepreneur, Co-founder of Koios Care |
| Known For | Digital health technology advancements |
| Education | Not specifically documented in available resources |
Early Life and Education
There is limited publicly available information regarding Gregor Strobbe’s early life and educational background. However, his professional trajectory is closely associated with innovations in health technology, indicating a strong foundation in medical or technological studies, likely pursued in Belgium where he is based. Strobbe’s role in founding Koios Care suggests he has significant experience and pertinent knowledge in technology-driven healthcare solutions.
Career and Notable Achievements
Gregor Strobbe is primarily known for his role in the establishment of Koios Care, where he has been instrumental in:
- Founding Koios Care (2022): Along with co-founders Konstantinos Kyritsis and Dimitris Iakovakis, Strobbe launched the startup focusing on AI integration in neurology to enhance the monitoring and treatment of Parkinson's disease.
- Development of Parkiwatch: This AI-powered platform passively collects data from wearable devices to provide actionable insights into the daily lives of patients, improving clinical decision-making and quality of care.
- Funding and Expansion: Successfully led the startup to secure multiple funding rounds, enhancing the company's capability to expand its innovative health solutions across Europe.
Current Work and Impact
Gregor Strobbe continues to play a pivotal role in leading Koios Care towards adopting innovative AI solutions in health monitoring. His efforts in merging technology with neurology have positioned the company as a leader in providing continuous, data-driven insights that empower both patients and healthcare providers. This alignment of digital health technology with real-world applications continues to influence the broader healthcare industry by pioneering more personalized and effective treatment strategies.
Conclusion
Gregor Strobbe’s contributions through Koios Care highlight his significant influence in the digital health tech industry. By focusing on facilitating real-world data collection through AI, Strobbe and his team have created platforms that are likely to revolutionize how neurological diseases, particularly Parkinson’s, are monitored and managed. As the company expands its reach and capabilities, Strobbe's ongoing work promises to set new standards in personalized and effective patient care, potentially transforming the healthcare landscape globally.